The current state of oncogenes and cancer: experimental approaches for analyzing oncogenetic events in human cancer
- PMID: 2208569
- DOI: 10.1007/BF00047589
The current state of oncogenes and cancer: experimental approaches for analyzing oncogenetic events in human cancer
Abstract
The development of cancer is a multistage process. The activation of proto-oncogenes and the inactivation of tumor suppressor genes play a critical role in the induction of tumors. Using human cell model systems of carcinogenesis, we have studied how oncogenes, tumor suppressor genes, and recessive cancer susceptibility genes participate in this multistep process. Normal human cells are resistant to the transforming potential of oncogenes, such as ras oncogenes, which are activated by specific point mutations. Since as many as 40% of some tumor types contain activated ras oncogenes, a preneoplastic transition in multistage carcinogenesis must involve changing from an oncogene-resistant stage to an oncogene-susceptible stage. The analysis of such critical steps in carcinogenesis using rodent systems has usually not represented the human disease with fidelity. In order to study this carcinogenic process, we have developed human cell, in vitro systems that represent some of the genetic changes that occur in cellular genes during human carcinogenesis. Using these systems, we have learned some of the functions of dominant activated-transforming oncogenes, tumor suppressor genes, and cellular immortalization genes and how they influence the carcinogenic process in human cells. Using our understanding of these processes, we are attempting to clone critical genes involved in the etiology of familial cancers. These investigations may help us to develop procedures that allow us to predict, in these cancer families, which individuals are at high risk for developing cancer.
Similar articles
-
Role of proto-oncogene activation in carcinogenesis.Environ Health Perspect. 1992 Nov;98:13-24. doi: 10.1289/ehp.929813. Environ Health Perspect. 1992. PMID: 1486840 Free PMC article. Review.
-
Mechanism of carcinogenesis: the role of oncogenes, transcriptional enhancers and growth factors.Anticancer Res. 1985 Sep-Oct;5(5):485-98. Anticancer Res. 1985. PMID: 3904595
-
Molecular mechanisms of ultraviolet radiation carcinogenesis.Photochem Photobiol. 1990 Dec;52(6):1119-36. doi: 10.1111/j.1751-1097.1990.tb08452.x. Photochem Photobiol. 1990. PMID: 2087500 Review.
-
Proto-oncogene activation in rodent and human tumors.Adv Exp Med Biol. 1991;283:235-43. doi: 10.1007/978-1-4684-5877-0_23. Adv Exp Med Biol. 1991. PMID: 2068988 Review.
-
PA-1, a human cell model for multistage carcinogenesis: oncogenes and other factors.Anticancer Res. 1988 Sep-Oct;8(5A):899-913. Anticancer Res. 1988. PMID: 3052262 Review.
Cited by
-
Tyrosine kinase inhibitors _targeted to the epidermal growth factor receptor subfamily: role as anticancer agents.Drugs. 2000 Apr;59(4):753-67. doi: 10.2165/00003495-200059040-00003. Drugs. 2000. PMID: 10804033 Review.
-
-148 C/T polymorphism of Axin2 contributes to a decreased risk of cancer: evidence from a meta-analysis.Onco _targets Ther. 2015 Jul 29;8:1957-66. doi: 10.2147/OTT.S86738. eCollection 2015. Onco _targets Ther. 2015. PMID: 26251618 Free PMC article.
-
Antibody Therapeutics in Oncology.Immunotherapy (Los Angel). 2016 Mar;2(1):108. Epub 2016 Feb 1. Immunotherapy (Los Angel). 2016. PMID: 27081677 Free PMC article.
-
Protein deubiquitylase USP3 stabilizes Aurora A to promote proliferation and metastasis of esophageal squamous cell carcinoma.BMC Cancer. 2021 Nov 10;21(1):1196. doi: 10.1186/s12885-021-08934-x. BMC Cancer. 2021. PMID: 34758762 Free PMC article.
-
Prognostic significance of the expression of c-fos, c-jun and c-erbB-1 oncogene products in human squamous cell lung carcinomas.J Cancer Res Clin Oncol. 1993;119(9):507-10. doi: 10.1007/BF01686458. J Cancer Res Clin Oncol. 1993. PMID: 8100821
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Other Literature Sources